Asia Pacific Aesthetic Injectable Market, 2026-2033
- MedTech
- Aesthetic Devices
- Aesthetic Injectable Market
- Aesthetic Devices
Global Market
Related Markets
Ask Prism AI about the aesthetic injectable market
Get cited answers from GVR research on market growth, segments, regulations and forecasts.
- Source-linked answers
- Market-specific context
- Traceable figures
Asia Pacific aesthetic injectable market highlights
- The Asia Pacific aesthetic injectable market generated a revenue of USD 3,366.9 million in 2025.
- The market is expected to grow at a CAGR of 11.9% from 2026 to 2033.
- In terms of segment, botulinum toxin (botox) was the largest revenue generating product in 2025.
- PN/PDRN is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Vietnam is expected to register the highest CAGR from 2026 to 2033.
Asia Pacific data book summary
| Market revenue in 2025 | USD 3,366.9 million |
| Market revenue in 2033 | USD 8,337.2 million |
| Growth rate | 11.9% (CAGR from 2026 to 2033) |
| Largest segment | Botulinum toxin (botox) |
| Fastest growing segment | PN/PDRN |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Collagen and PMMA Microspheres, Hyaluronic Acid, Calcium Hydroxylapatite (CaHA), PLLA, PCL, PN/PDRN, Botulinum Toxin (Botox) |
| Key market players worldwide | Ipsen SA, AbbVie Inc, Merz Pharma, Galderma Group AG Registered Shares, Prollenium Medical Technologies, Suneva Medical, Sinclair Pharma plc, Medytox, Revance Therapeutics Inc |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 30.3% of the global aesthetic injectable market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 8,337.2 million by 2033.
China, India, and Japan are developing economies and key revenue contributors to the Asia Pacific aesthetic injectable market. With rapidly developing economies, the market is expected to witness rapid growth. This can be attributed to the growing medical tourism industry, especially in Southeast Asia.
According to the ISAPS 2022 report, 29% of the patients undergoing aesthetic treatment in Thailand were foreign nationals. The growing preference among foreign nationals to undergo treatments in Thailand can be attributed to the availability of advanced techniques and cost-effective treatment options.
The growing disposable income in various countries, increasing patient awareness, and rising geriatric population are among the major factors expected to drive the market. According to the Asian Development Bank (ADB), one in four people in the region is expected to be aged 60 years or above by 2050.
No credit card required*
Publish Date: Apr 28, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Aesthetic Injectable Market
Aesthetic Injectable Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| AbbVie Inc | View profile | 50,000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | www.abbvieinvestor.com |
| Galderma Group AG Registered Shares | View profile | - | Zählerweg 10, Zug, Switzerland, 6300 | www.galderma.com |
| Revance Therapeutics Inc | View profile | 597 | 1222 Demonbreun Street, Suite 2000, Nashville, TN, United States, 37203 | www.revance.com |
| Merz Pharma | View profile | 5001-10000 | Deutsch, Sachsen, Germany, Europe | www.merz.com |
| Suneva Medical | View profile | 101-250 | San Diego, California, United States, North America | sunevamedical.com |
| Prollenium Medical Technologies | View profile | 101-250 | Richmond Hill, Ontario, Canada, North America | prollenium.com |
| Sinclair Pharma plc | View profile | 501-1000 | London, England, United Kingdom, Europe | www.sinclairpharma.com/ |
| Medytox | View profile | 501-1000 | Seoul, Seoul-t'ukpyolsi, South Korea, Asia | www.medytox.com/page/company_en?site_id=en |
| Ipsen SA | View profile | 5,325 | 65 Quai Georges Gorse, Billancourt Cedex, Boulogne, France, 92100 | www.ipsen.com |
Asia Pacific Aesthetic Injectable Market
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Aesthetic Injectable Market will help companies and investors design strategic landscapes.
Botulinum Toxin (Botox) was the largest segment with a revenue share of 51.94% in 2025.
Horizon Databook has segmented the Asia Pacific aesthetic injectable market based on collagen and pmma microspheres, hyaluronic acid, calcium hydroxylapatite (caha), plla, pcl, pn/pdrn, botulinum toxin (botox) covering the revenue growth of each sub-segment from 2021 to 2033.
China, India, and Japan are developing economies and key revenue contributors to the Asia Pacific aesthetic injectable market. With rapidly developing economies, the market is expected to witness rapid growth. This can be attributed to the growing medical tourism industry, especially in Southeast Asia.
According to the ISAPS 2022 report, 29% of the patients undergoing aesthetic treatment in Thailand were foreign nationals. The growing preference among foreign nationals to undergo treatments in Thailand can be attributed to the availability of advanced techniques and cost-effective treatment options.
The growing disposable income in various countries, increasing patient awareness, and rising geriatric population are among the major factors expected to drive the market. According to the Asian Development Bank (ADB), one in four people in the region is expected to be aged 60 years or above by 2050.
- Asia Pacific Aesthetic Injectable Market Product Outlook (Revenue, USD Million , 2021-2033)
- Collagen and PMMA Microspheres
- Hyaluronic Acid
- Calcium Hydroxylapatite (CaHA)
- PLLA
- PCL
- PN/PDRN
- Botulinum Toxin (Botox)
- Asia Pacific Aesthetic Injectable Market Application Outlook (Revenue, USD Million , 2021-2033)
- Wrinkle Correction
- Lip Augmentation
- Facial Contouring
- Scar Treatment
- Volume Loss Restoration
- Others
- Asia Pacific Aesthetic Injectable Market End Use Outlook (Revenue, USD Million , 2021-2033)
- MedSpas
- Aesthetic Surgery Centers
- Hospitals
- Others
Reasons to subscribe to Aesthetic Injectable Market databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Aesthetic Injectable Market databook
- Our clientele includes a mix of Aesthetic Injectable Market companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific Aesthetic Injectable Market, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific Aesthetic Injectable Market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Asia Pacific Aesthetic Injectable Market, 2021-2033 (US$M)
Asia Pacific Product - Aesthetic Injectable Market, 2025 - 2033 (US$M)
